Early Access — free while we kick the tires
EdgarHawk

Montgomery Kenneth C.

Director

Director
2 filings analyzed · 1 company · Latest 2025-09-15

Companies

Company Buys Sells Direction
NB Bancorp, Inc. NBBK 2 0 Net buying

Activity

September 2025
2025-09-15 NB Bancorp, Inc. NBBK
medium
Buy
5,000 shares
$92,200
Significance 4/10

Director Montgomery Kenneth C. purchases 5,000 NBBK shares at $18.44; holdings rise to 80,337 shares post-transaction.

Kenneth Montgomery, a director of NB Bancorp, Inc., purchased 5,000 shares at $18.44 on 2025-09-12, increasing his stake by 6.6% to 80,337 shares. The transaction occurred near the bottom of the 52-week trading range ($15.76–$20.94), approximately 11.2% below the 52-week high. His prior purchase at NBBK on 2024-09-19 showed a 90-day return of +2.4%, consistent with his cross-ticker track record of a 100.00% 90-day win rate across 1 prior open-market buy. Current price at $18.60 reflects a 3.0% gain over the prior 30 days and 15.7% gain over 90 days, placing the stock in positive momentum territory. The company's P/E of 14.42 and market cap of $740.8M suggest a smaller regional bank with modest valuation multiples.

September 2024
2024-09-20 NB Bancorp, Inc. NBBK
low
Buy
100 shares
$1,862
Significance 3/10

Director Montgomery buys initial 100 shares of NBBK at $18.62; stock at $18.36 with P/E of 61.20

Montgomery Kenneth C., a director of NB Bancorp, purchased 100 shares at $18.62 on 2024-09-19, establishing an initial position. The purchase occurred within the stock's 52-week range of $13.32–$19.16, near recent highs. Despite positive momentum (90-day change: +24.9%), the company trades at a P/E of 61.20 against net income of $9,453,000.00, suggesting a relatively elevated valuation. The modest transaction size and initiation of holdings warrant monitoring, though the limited position accumulation provides minimal signal on director-level conviction at this valuation level.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access